|
|
|
Volumn 22, Issue 139, 2013, Pages 155-159
|
|
Bleeding with dabigatran, rivaroxaban, apixaban: No antidote, and little clinical experience
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALISKIREN;
AMIODARONE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIFUNGAL AGENT;
ANTITHROMBOCYTIC AGENT;
APIXABAN;
ATORVASTATIN;
BEPRIDIL;
CARDIOVASCULAR AGENT;
CREATININE;
DABIGATRAN;
DIHYDROQUINIDINE;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DRONEDARONE;
ENOXAPARIN;
HEPARIN;
NICARDIPINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROPAFENONE;
PROTHROMBIN COMPLEX;
QUINIDINE;
RANOLAZINE;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
RIVAROXABAN;
UNINDEXED DRUG;
VERAPAMIL;
WARFARIN;
ARTICLE;
BLEEDING;
BLOOD CLOTTING TEST;
BODY WEIGHT;
BRAIN HEMORRHAGE;
CREATININE CLEARANCE;
DISEASE SEVERITY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG FATALITY;
DRUG INDICATION;
DRUG MARKETING;
DRUG MEGADOSE;
DRUG METABOLISM;
DRUG OVERDOSE;
DRUG SURVEILLANCE PROGRAM;
DRUG WITHDRAWAL;
GASTROINTESTINAL HEMORRHAGE;
GROUPS BY AGE;
HEMODIALYSIS;
HIGH RISK POPULATION;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
INVASIVE PROCEDURE;
KIDNEY FAILURE;
LABORATORY TEST;
LOW DRUG DOSE;
MEDICATION ERROR;
PARTIAL THROMBOPLASTIN TIME;
POLYPHARMACY;
PRACTICE GUIDELINE;
RISK FACTOR;
SURGICAL PATIENT;
THROMBOSIS;
THROMBOSIS PREVENTION;
ANTICOAGULANTS;
ANTIDOTES;
BENZIMIDAZOLES;
BETA-ALANINE;
BLOOD COAGULATION TESTS;
DRUG OVERDOSE;
HEMORRHAGE;
HUMANS;
MORPHOLINES;
PYRAZOLES;
PYRIDONES;
THIOPHENES;
|
|
EID: 84880783433
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (13)
|
|
References (5)
|
